Trials / Terminated
TerminatedNCT00616343
Zonisamide in the Treatment of Essential Tremor
Pilot Study of Zonisamide in the Treatment of Essential Tremor
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Loma Linda University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if Zonisamide is effective in reducing tremors in patients with Essential Tremor.
Detailed description
The subjects will remain on their usual medication and a baseline assessment using the Fahn Tolosa Marin tremor rating scale will be performed and will be video taped.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zonisamide | 100mg tablets once a day for two weeks, then increased to 200mg qhs for two weeks. |
Timeline
- Start date
- 2003-06-01
- Primary completion
- 2012-10-01
- Completion
- 2012-12-01
- First posted
- 2008-02-15
- Last updated
- 2014-07-17
- Results posted
- 2014-07-17
Source: ClinicalTrials.gov record NCT00616343. Inclusion in this directory is not an endorsement.